This award supports new, highly innovative, hypothesis-driven research projects focused on interventions to improve outcomes for persons living with Hepatic Encephalopathy from liver diseases. Projects must include direct clinical interaction, patient clinical data, or patient samples, and be completable within one year with 1-2 aims. The award provides $50,000 for research conducted at accredited non-profit institutions in the US, Canada, or Mexico.
Applicants must be Early-Stage Investigators up to Associate Professor rank, AASLD members, and sponsored by accredited non-profit institutions in the US, Canada, or Mexico. NIH, FDA, and CDC employees are ineligible.
